E79
Disorders of purine and pyrimidine metabolism
Exclusions 18 never code together
- Ataxia-telangiectasia (Q87.19)Q87.19Q87.19Q87.19
- Bloom's syndrome (Q82.8)Q82.8Q82.8Q82.8
- Cockayne's syndrome (Q87.19)Q87.19Q87.19Q87.19
- calculus of kidney (N20.0)N20.0N20.0N20.0
- combined immunodeficiency disorders (D81.-)D81.-D81.-D81.-
- Fanconi's anemia (D61.09)D61.09D61.09D61.09
- gout (M1A.-, M10.-)M1A.-M1A.-M1A.-M10.-M10.-M10.-
- orotaciduric anemia (D53.0)D53.0D53.0D53.0
- progeria (E34.8)E34.8E34.8E34.8
- Werner's syndrome (E34.8)E34.8E34.8E34.8
- xeroderma pigmentosum (Q82.1)Q82.1Q82.1Q82.1
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes 1
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here filed at null
No alphabetic index entry points at this code.
Subordinate codes 5
Medications 5
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.